151.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Gilead Sciences Inc Borsa (GILD) Ultime notizie
RBC raises target for Gilead Sciences stock to USD 126.00 - AD HOC NEWS
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings - Zacks Investment Research
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD) - Yahoo! Finance Canada
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD) - Yahoo Finance
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - MarketBeat
Cantor Fitzgerald Reaffirms Overweight Rating for Gilead Sciences (NASDAQ:GILD) - MarketBeat
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD) - TradingView
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Gilead Sciences (NASDAQ:GILD) Stock Gets Price Target Boost from JPMorgan Chase & Co. - MarketBeat
U.S. Stocks Slip Ahead of Fed Minutes; Gilead Sciences (GILD) Ga - GuruFocus
Gilead Sciences (NASDAQ:GILD) Stock Price Target Cut by Morgan Stanley - MarketBeat
Gilead Sciences Is Maintained at Overweight by Morgan Stanley - Moomoo
Gilead Sciences stock gains 2.57 percent after AI agreement expands - AD HOC NEWS
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX) - Benzinga
JPMorgan Adjusts Price Target on Gilead Sciences to $170 From $160 - marketscreener.com
Gilead Sciences signs five-year DevOps agreement with Cognizant - Pharmaceutical Technology
Gilead Sciences signs five-year DevOps agreement with Cognizant - Yahoo Finance
Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences - PR Newswire
Drugmaker Gilead gets AI support for selected tech programs under a five-year extension - Stock Titan
12,110 Gilead Sciences, Inc. $GILD Shares Sold by CapWealth Advisors LLC - MarketBeat
Gilead Sciences (NASDAQ:GILD) Offers Dividend Investors Quality Income and Valuation Support - ChartMill
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Motley Fool
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know - Zacks Investment Research
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Under a prearranged trading plan, Gilead Sciences (GILD) CEO sells 15,000 shares. - Stock Titan
Gilead Sciences Inc. stock underperforms Friday when compared to competitors - MarketWatch
Confluence Investment Management LLC Cuts Position in Gilead Sciences, Inc. $GILD - MarketBeat
More Upside Awaits for Gilead Sciences Stock. Stay Invested. - Barron's
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Zacks Investment Research
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors - Zacks Investment Research
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors - Yahoo Finance
Gilead Sciences stock reports growth at EUR 133.42, plus 0.02 percent - AD HOC NEWS
Gilead Sciences (NASDAQ:GILD) Stock: Stronger HIV Sales Meet Weaker Reported Earnings - kalkine.ca
Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase? - finance.yahoo.com
Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? - Yahoo Finance
Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing? - finance.yahoo.com
Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend? - Yahoo Finance
CEUX:GISd Dividend: Does Gilead Sciences Inc Pay a Dividend? - GuruFocus
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? - finance.yahoo.com
Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification? - Yahoo Finance
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts - MarketBeat
Gilead Sciences, Inc. $GILD Stake Decreased by Envestnet Asset Management Inc. - MarketBeat
Gilead Sciences Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Gilead Sciences stock slips 0.85 percent ahead of the open - AD HOC NEWS
Gilead: HIV Growth Is Not Enough At The Current Price (NASDAQ:GILD) - Seeking Alpha
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH - The Motley Fool
Gilead Sciences (GILD) Stock Moves 1.40%: What You Should Know - Yahoo Finance
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):